Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
PTCT Insider Trading and Fund Holdings (PTC THERAPEUTICS, INC.) · https://wallstpal.com/stock/ptct/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
StockCIK 1070081

PTC THERAPEUTICS, INC. (PTCT): Insider Trades and Fund Holdings

In the past 12 months, PTC THERAPEUTICS, INC. insiders reported no open-market purchases and 28 sales worth $22.1M; 28 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months
$0Bought by insiders, 12 months
$22.1MSold by insiders, 12 months
1Tracked funds holding

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.

  1. Oct 14, 2026Insider saleDirector Michael Schmertzler sold $149,036 under a 10b5-1 plan
  2. Oct 9, 2026Insider saleGeneral Counsel Mark Elliott Boulding sold $12,338 under a 10b5-1 plan
  3. Oct 9, 2026Planned saleBoulding Mark Elliott (officer) filed notice to sell about $12,339 around Oct 9, 2026
  4. Oct 7, 2026Insider saleDirector Michael Schmertzler sold $158,480 under a 10b5-1 plan
  5. Oct 7, 2026Planned saleSection Six Partners, L.P. (affiliate of director) filed notice to sell about $643,500 around Oct 7, 2026
  6. Oct 6, 2026Insider saleGeneral Counsel Mark Elliott Boulding sold $27,910 under a 10b5-1 plan
  7. Oct 6, 2026Planned saleBoulding Mark Elliott (officer) filed notice to sell about $27,908 around Oct 6, 2026
  8. Oct 5, 2026Insider saleGeneral Counsel Mark Elliott Boulding sold $104,881 under a 10b5-1 plan
  9. Oct 5, 2026Planned saleBoulding Mark Elliott (officer) filed notice to sell about $104,883 around Oct 5, 2026
  10. Sep 30, 2026Insider saleDirector Steele Glenn Jr Md Phd sold $781,920 under a 10b5-1 plan
  11. Sep 30, 2026Planned saleSTEELE GLENN JR MD PHD (director) filed notice to sell about $781,920 around Sep 30, 2026
  12. Sep 17, 2026Insider saleDirector Michael Schmertzler sold $678,533 under a 10b5-1 plan
  13. Sep 16, 2026Insider saleDirector Michael Schmertzler sold $671,195 under a 10b5-1 plan
  14. Sep 10, 2026Insider saleDirector Michael Schmertzler sold $673,400 under a 10b5-1 plan
  15. Sep 9, 2026Insider saleDirector Michael Schmertzler sold $678,403 under a 10b5-1 plan
  16. Sep 9, 2026Planned saleSection Six Partners, L.P. (affiliate of director) filed notice to sell about $2.7 million around Sep 9, 2026
  17. Aug 28, 2026NewsCompany reported: Signed a material agreement
  18. Aug 27, 2026Insider saleDirector Michael Schmertzler sold $894,784 under a 10b5-1 plan
  19. Aug 26, 2026Insider saleDirector Michael Schmertzler sold $911,726 under a 10b5-1 plan
  20. Aug 25, 2026Planned saleSection Six Partners, L.P. (affiliate of director) filed notice to sell about $3.6 million around Aug 19, 2026
  21. Aug 20, 2026Insider saleDirector Michael Schmertzler sold $888,858 under a 10b5-1 plan
  22. Aug 19, 2026Insider saleDirector Michael Schmertzler sold $916,554 under a 10b5-1 plan
  23. Aug 19, 2026Planned saleMichael Schmertzler (director) filed notice to sell about $3.6 million around Aug 19, 2026
  24. Aug 17, 2026Insider saleGeneral Counsel Mark Elliott Boulding sold $204,127 under a 10b5-1 plan
  25. Aug 17, 2026Planned saleBoulding Mark Elliott (officer) filed notice to sell about $201,692 around Aug 17, 2026
  26. Aug 4, 2026Insider saleCEO Matthew B. Klein sold $705,722 under a 10b5-1 plan (5 days after: quarterly or annual results)
  27. Aug 4, 2026Planned saleKlein Matthew B. (officer, director) filed notice to sell about $705,754 around Aug 4, 2026
  28. Jul 30, 2026NewsCompany reported: Quarterly or annual results; Executive or director change
  29. Jul 14, 2026Insider saleCFO Pierre Gravier sold $280,743 under a 10b5-1 plan
  30. Jul 9, 2026Insider saleDirector Mary L. Smith sold $1.4 million under a 10b5-1 plan
  31. Jul 9, 2026Insider saleCHIEF TECHNICAL OPS OFFICER Neil Gregory Almstead sold $222,376 under a 10b5-1 plan
  32. Jul 7, 2026Insider saleCHIEF TECHNICAL OPS OFFICER Neil Gregory Almstead sold $2.2 million under a 10b5-1 plan
  33. Jul 6, 2026Insider saleCHIEF TECHNICAL OPS OFFICER Neil Gregory Almstead sold $1.9 million under a 10b5-1 plan
  34. Jul 6, 2026Insider saleGeneral Counsel Mark Elliott Boulding sold $432,118 under a 10b5-1 plan
  35. Jun 30, 2026FundRenaissance Technologies added 36% in Q2 2026 (13F filed Aug 13, 2026)
  36. Jun 26, 2026Insider saleCHIEF TECHNICAL OPS OFFICER Neil Gregory Almstead sold $693,152 under a 10b5-1 plan
  37. Jun 25, 2026Insider saleCHIEF TECHNICAL OPS OFFICER Neil Gregory Almstead sold $1.8 million under a 10b5-1 plan
  38. Jun 24, 2026Insider saleCHIEF TECHNICAL OPS OFFICER Neil Gregory Almstead sold $452,607 under a 10b5-1 plan
  39. Jun 22, 2026Insider saleCHIEF TECHNICAL OPS OFFICER Neil Gregory Almstead sold $1.9 million under a 10b5-1 plan
  40. Jun 17, 2026Insider saleCAO Christine Marie Utter sold $1.5 million under a 10b5-1 plan

Showing the latest 40 of 41 events.

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 16, 2026.

Recent PTCT insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHoldingFiling
Oct 16Oct 14Michael SchmertzlerDirectorDirector (ind.)▼ SELL10b5-12,50059.61$149K−0.2%Form 4 ↗
Oct 13Oct 9Mark Elliott BouldingGeneral CounselGeneral Counsel▼ SELL10b5-119264.26$12K−0.2%Form 4 ↗
Oct 9Oct 7Michael SchmertzlerDirectorDirector (ind.)▼ SELL10b5-12,50063.39$158K−0.2%Form 4 ↗
Oct 7Oct 5Mark Elliott BouldingGeneral CounselGeneral Counsel▼ SELL10b5-11,63864.03$105K−1.5%Form 4 ↗
Oct 7Oct 6Mark Elliott BouldingGeneral CounselGeneral Counsel▼ SELL10b5-143564.16$28K−0.4%Form 4 ↗
Oct 2Sep 30Steele Glenn Jr Md PhdDirectorDirector▼ SELL10b5-112,00065.16$782K−35%Form 4 ↗
Sep 18Sep 17Michael SchmertzlerDirectorDirector (ind.)▼ SELL10b5-110,00067.85$679K−0.8%Form 4 ↗
Sep 18Sep 16Michael SchmertzlerDirectorDirector (ind.)▼ SELL10b5-110,00067.12$671K−0.8%Form 4 ↗
Sep 11Sep 9Michael SchmertzlerDirectorDirector (ind.)▼ SELL10b5-110,00067.84$678K−0.7%Form 4 ↗
Sep 11Sep 10Michael SchmertzlerDirectorDirector (ind.)▼ SELL10b5-110,00067.34$673K−0.8%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
All 28 PTCT insider trades →

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Michael SchmertzlerDirector0$010$6.62MOct 16, 2026
Mark Elliott BouldingGeneral Counsel0$06$1.60MOct 13, 2026
Steele Glenn Jr Md PhdDirector0$01$782KOct 2, 2026
Matthew B. KleinCEO0$01$706KAug 6, 2026
Pierre GravierCFO0$01$281KJul 16, 2026
Mary L. SmithDirector0$01$1.43MJul 13, 2026
Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER0$07$9.18MJul 13, 2026
Christine Marie UtterCAO0$01$1.49MJun 22, 2026
Filing quality

A All 28 insider trades reported on time. How it is graded

Tracked funds that report PTCT

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

FundQuarterSharesValue% of portfolioChange
Renaissance TechnologiesQ2 2026723,500$59.0M0.08%▲ +35.7%
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →